Abbott Aims To Quash Bayer Subpoena
Abbott Diabetes Care Inc. and parent Abbott Laboratories have called on a federal court to quash Bayer HealthCare LLC's subpoena demanding information from a patent settlement that is alleged to be...To view the full article, register now.
Already a subscriber? Click here to view full article